Pavan S. Reddy

6.8k total citations
34 papers, 1.2k citations indexed

About

Pavan S. Reddy is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Pavan S. Reddy has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Pavan S. Reddy's work include Bone health and treatments (5 papers), Vitamin D Research Studies (5 papers) and Cancer survivorship and care (5 papers). Pavan S. Reddy is often cited by papers focused on Bone health and treatments (5 papers), Vitamin D Research Studies (5 papers) and Cancer survivorship and care (5 papers). Pavan S. Reddy collaborates with scholars based in United States, Canada and India. Pavan S. Reddy's co-authors include Karen M. Mustian, Charles E. Heckler, Michelle C. Janelsins, Luke J. Peppone, Vasudha Bakshi, Bruce F. Kimler, Jennifer R. Klemp, Qamar J. Khan, Lisa K. Sprod and Carol J. Fabian and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Ophthalmology and The Oncologist.

In The Last Decade

Pavan S. Reddy

29 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pavan S. Reddy United States	13	688	219	194	185	128	34	1.2k
Magdalena Kocot-Kępska Poland	17	463 0.7×	115 0.5×	134 0.7×	516 2.8×	120 0.9×	52	1.4k
Po‐Ju Lin United States	19	588 0.9×	217 1.0×	109 0.6×	292 1.6×	27 0.2×	73	1.1k
Zoë Yates Australia	23	137 0.2×	46 0.2×	67 0.3×	127 0.7×	212 1.7×	55	1.4k
Alessandro Delitala Italy	27	120 0.2×	105 0.5×	17 0.1×	201 1.1×	129 1.0×	82	1.9k
Cynthia A. Stuenkel United States	26	297 0.4×	96 0.4×	31 0.2×	102 0.6×	473 3.7×	68	2.6k
María J. Martínez de Osaba Spain	22	292 0.4×	65 0.3×	54 0.3×	55 0.3×	120 0.9×	49	1.2k
L. M. Demers United States	22	279 0.4×	176 0.8×	18 0.1×	111 0.6×	88 0.7×	30	1.4k
Ece Böber Türkiye	23	60 0.1×	86 0.4×	48 0.2×	205 1.1×	131 1.0×	145	1.7k
Fiona Streckmann Germany	13	765 1.1×	128 0.6×	248 1.3×	228 1.2×	32 0.3×	26	1.1k
Ole‐Petter R. Hamnvik United States	20	341 0.5×	258 1.2×	9 0.0×	425 2.3×	78 0.6×	48	1.8k

Countries citing papers authored by Pavan S. Reddy

Since Specialization

Citations

This map shows the geographic impact of Pavan S. Reddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavan S. Reddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavan S. Reddy more than expected).

Fields of papers citing papers by Pavan S. Reddy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavan S. Reddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavan S. Reddy. The network helps show where Pavan S. Reddy may publish in the future.

Co-authorship network of co-authors of Pavan S. Reddy

This figure shows the co-authorship network connecting the top 25 collaborators of Pavan S. Reddy. A scholar is included among the top collaborators of Pavan S. Reddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavan S. Reddy. Pavan S. Reddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Okut, Hayrettin, Shaker R. Dakhil, Christopher Dakhil, et al.. (2024). Real-world safety and discontinuation rates of fam-trastuzumab deruxtecan in advanced HER2-positive and HER2-low cancer.. Journal of Clinical Oncology. 42(16_suppl). e12518–e12518.

Kalemkerian, Gregory P., Humera Khurshid, Nofisat Ismaila, et al.. (2024). Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update. Journal of Clinical Oncology. 43(1). 101–105. 5 indexed citations

Navari, Rudolph M., Jennifer Le‐Rademacher, Fabrice Smieliauskas, et al.. (2023). Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602). The Oncologist. 28(8). 722–729. 1 indexed citations

Reddy, Pavan S., et al.. (2023). Rare Loxoscelism-Associated IgG Coombs-Positive Hemolytic Anemia Treated Successfully With Systemic Corticosteroids. Cureus. 15(10). e47424–e47424.

Choucair, Khalil, Bassam Mattar, Dennis F. Moore, et al.. (2022). Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World Experience. Clinical Breast Cancer. 23(2). 155–161.

Navari, Rudolph M., Jennifer Le‐Rademacher, Fabrice Smieliauskas, et al.. (2022). Olanzapine with or without an NK-1 receptor antagonist for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy: A phase III randomized, double-blind, placebo-controlled trial (ALLIANCE A221602).. Journal of Clinical Oncology. 40(16_suppl). 12107–12107. 1 indexed citations

Saylor, Philip J., R. Bryan Rumble, Scott T. Tagawa, et al.. (2020). Bone Health and Bone-Targeted Therapies for Prostate Cancer: ASCO Endorsement of a Cancer Care Ontario Guideline. Journal of Clinical Oncology. 38(15). 1736–1743. 55 indexed citations

Sparano, Joseph A., Robert J. Gray, William C. Wood, et al.. (2018). TAILORx: Phase III trial of chemoendocrine therapy versus endocrine therapy alone in hormone receptor-positive, HER2-negative, node-negative breast cancer and an intermediate prognosis 21-gene recurrence score.. Journal of Clinical Oncology. 36(18_suppl). LBA1–LBA1. 8 indexed citations

Kleckner, Ian R., Charles Kamen, Jennifer S. Gewandter, et al.. (2017). Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Supportive Care in Cancer. 26(4). 1019–1028. 216 indexed citations

10.

Khan, Qamar J., Bruce F. Kimler, Pavan S. Reddy, et al.. (2017). Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial. Breast Cancer Research and Treatment. 166(2). 491–500. 38 indexed citations

11.

Reddy, Pavan S., et al.. (2016). Beneficial effect of Curcumin in Letrozole induced polycystic ovary syndrome. Asian Pacific Journal of Reproduction. 5(2). 116–122. 102 indexed citations

12.

Peppone, Luke J., Michelle C. Janelsins, Anita R. Peoples, et al.. (2013). Effect of YOCAS yoga on insomnia and sleep medication usage among breast cancer patients receiving hormone therapy: A URCC CCOP randomized, controlled clinical trial.. Journal of Clinical Oncology. 31(15_suppl). 9531–9531. 2 indexed citations

13.

Khan, Qamar J., Bruce F. Kimler, Pavan S. Reddy, et al.. (2012). Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms and fatigue in women with breast cancer starting adjuvant letrozole: The VITAL trial.. Journal of Clinical Oncology. 30(15_suppl). 9000–9000. 13 indexed citations

14.

Barton, Debra L., Edward J. Wos, Rui Qin, et al.. (2010). A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Supportive Care in Cancer. 19(6). 833–841. 195 indexed citations

15.

Hines, Stephanie L., Jeff A. Sloan, Philip J. Atherton, et al.. (2010). Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy. The Breast. 19(2). 92–96. 24 indexed citations

16.

Khan, Qamar J., Pavan S. Reddy, Bruce F. Kimler, et al.. (2009). Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Research and Treatment. 119(1). 111–118. 146 indexed citations

17.

El‐Osta, Hazem, et al.. (2009). Acquired factor VIII inhibitors: case reports of paclitaxel and penicillin – induced entities. Blood Coagulation & Fibrinolysis. 20(8). 719–721. 6 indexed citations

18.

Khan, Qamar J., et al.. (2008). Effect of high-dose vitamin D on joint pain and fatigue from adjuvant letrozole. Journal of Clinical Oncology. 26(15_suppl). 9618–9618. 2 indexed citations

19.

Reddy, Pavan S., et al.. (2004). Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura. Annals of Hematology. 84(4). 232–235. 54 indexed citations

20.

Crock, G. W., et al.. (1986). Intraocular magnet of Parel.. British Journal of Ophthalmology. 70(12). 879–885. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact